Products

What will AGI do for Bemitradine?

This classification denotes a diuretic with the molecular formula C15H17N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LT9004D9N0, chemically known as 8-(2-ethoxyethyl)-7-phenyl-(1,2,4)triazolo(1,5-c)pyrimidin-5-amine but generally known as bemitradine, which bears US NIH Compound Identifier 55784. European Medicines Agency schedules Bemitradine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05694MIG. The term BEMITRADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). BEMITRADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bemitradine under HS 29335995 and SITC 51576. As of Q4 2014, BEMITRADINE remains the US FDA Preferred Term for this commodity. Bemitradine bears US NLM identifiers UMLS ID C0165297 and NCI Concept Code C77556. SMILES: O(CCC1C(NC(N2NCNC12)N)C1CCCCC1)CC.

How AGI delivers it

Four ways AGI delivers for Bemitradine

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Bemitradine, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Bemitradine, get the professional outcome delivered as software, priced on results, not headcount.